Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
alpha-synuclein
Alzheimer's disease
amygdala
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, etiology of
amyotrophic lateral sclerosis, guamian type of
amyotrophic lateral sclerosis, Parkinson-dementia-complex
anticholinergic drugs
anticipation
ataxia
biologic markers
blacks
blinking, reduced
bradykinesia
brain transplantation
camptocormia
cardiomyopathy
CAT scan, emission
children
chronic progressive external ophthalmoplegia
cigarette smoking
cluster headache
cluster headache, pathogenesis
coenzyme Q10
controversies in neurology
cycad seed flour
DATATOP study
degenerative diseases of CNS
dementia
deprenyl
depression
diet
dopamine agonist
dopaminergic dysfunction
dopaminergic neurons
encephalitis
encephalitis, viral
encephalopathy
epidemiology of neurology
excitotoxin
exercise intolerance
eye, pain in
falling
familial
farmer
fetal tissue
fine motor function, impaired
free radical
gait disorder
gait, festinating
gene
gene mutation
gene therapy
genetic neurologic disorders
glabellar sign
handwriting
head injury
headache
headache, awakened by
headache, hypnic
headache, intractable
headache, severe
headache, unilateral
hearing loss
hepatic failure
hepatitis
hepatitis B virus
hepatitis C virus
herbicide
hypometric saccades
hypothalamus
hypothalamus, disturbance of
imbalance
imbalance, postural
insecticides
iron, brain
kinesia paradoxica
L-dopa
L-dopa, drug interactions with and side effects of
Lewy body
Lewy body disease, diffuse
locus ceruleus, lesion of
marche a petits pas
masked facies
micrographia
migraine
mitochondrial disease
mitochondrial disease, pathogenesis
molecular genetics
monoamine oxidase inhibitors
mortality
movement disorder
MPTP
MRI
MRI, functional
MRS
myopathy
neuroleptic, atypical
neurologic disease
neurologic disease, diagnoses of
neurologic signs
neuronal degeneration
neurons
neuropathology
neuropathology, brain
neuropathy
neuroprotective agents
neurotoxic
neurotoxin
nigrostriatal pathway
occupational neurologic disorders
old age, neurology of
ophthalmoplegia
ophthalmoplegia, progressive external
oxidative phosphorylation
oxidative phosphorylation defect
pain, deep brain stimulation for control of
pain, periorbital
pallidotomy
Parkinson disease
Parkinson disease, classification
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, etiology of
Parkinson disease, familial
Parkinson disease, freezing phenomena in
Parkinson disease, heterogeneity of
Parkinson disease, late onset
Parkinson disease, nonmotor problems of
Parkinson disease, pathogenesis of
Parkinson disease, prognosis of
Parkinson disease, racial prevalence
Parkinson disease, subtypes
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinson disease, young onset
Parkinsonism syndrome
pathology
placebo effect
poison, organophosphate
POLG1 gene
prevention of neurologic disorders
PRKN gene
prognosis
progressive neurologic disorder
psychosis
ptosis
raphe nuclei
review article
rigidity
risk factors
seizure
sinemet
single photon emission computed tomography
skin, biopsy
smell
speech, soft
stare
stem cell transplantation
stimulation, deep brain
strokelike episodes
substantia nigra
subthalamic nucleus
subthalamic nucleus deep brain stimulation
synucleinopathy
systemic illness
toxins, nervous system
treatment of neurologic disorder
tremor
tremor, resting
tremor, thalamic stimulation for suppression of
twins
viral infection
viral infection, CNS
vitamin E
web sites
Showing articles 900 to 950 of 1815 << Previous Next >>

Case-Control Study of Idiopathic Parkinson's Disease and Dietary Vitamin E Intake
Neurol 46:1270-1274, Morens,D.M.,et al, 1996

Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996

Survival & Prolif of Nonneural Tissu, with Obstr of Cereb Ventric, In Parkinson Pt Trt with Fetal Allografts
Neurol 46:1219-1225, Folkerth,R.D.&Durso,R., 1996

Diffuse Lewy Body Disease:Clinical Features in Nine Cases without Coexistent Alzheimer's Disease
JNNP 60:531-538, Hely,M.A.,et al, 1996

Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996

Gamma Knife Pallidotomy in Advanced Parkinson's Disease
Ann Neurol 39:535-538, Friedman,J.H.,et al, 1996

Transient Hemiballism/Hemichorea Dur to an Ipsilateral Subthalamic Nucleus Infarction
Neurol 46:267-268, Crozier,S.,et al, 1996

Hyperinsulinism and Cerebral Microangiopathy
Stroke 27:219-223, Zunker,P.,et al, 1996

Incorrect Diagnosis of Alzheimer's Disease:A Clinicopathologic Study
Arch Neurol 53:35-42, Klatka,L.A.,et al, 1996

Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Subjects Not Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:29-361996., , 1996

Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Patients Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:37-451996., , 1996

Nonmotor Fluctuations in Patients with Parkinson's Disease
Neurol 47:1180-1183, Hillen,M.E.&Sage,J.I., 1996

Clinical and Pathological Features in Hydrocarbon-Induced Parkinsonism
Ann Neurol 40:922-925, Pezzoli,G.,et al, 1996

Visual Hallucinations Associated with Parkinson Disease
Arch Neurol 53:1265-1268, Sanchez-Ramos,J.R.,et al, 1996

Liquid Levodopa/Carbidopa Produces Significant Improvement in Motor Function without Dyskinesia Exacerbation
Neurol 47:1493-1495, Pappert,E.J.,et al, 1996

Retroperitoneal Fibrosis in a Patient with Parkinson's Disease Treated with Pergolide
Clin NeuroPharmacol 18:277-279, Jimenez-Jimenez,F.J.,et al, 1995

Lambert-Eaton Myasthenic Syndrome:Clinical Diagnosis,Immune-Mediated Mechanisms,and Update on Therapies
Ann Neurol 37:S63-S73, Sanders,D.B., 1995

Disabling Parkinsonism Due to Lithium: A Case Report
J Geriatr Psychiatry Neurol 8:118-119, Holroyd,S. & Smith,D., 1995

Extrapyramidal Symptoms in a BMT Recipient with Hyperintense Basal Ganglia and Elevated Manganese
Bone Marrow Transplantation 15:989-992, Fredstrom,S.,et al, 1995

The Effect of Deprenyl and Levodopa on the Progression of Parkinson's Disease
Ann Neurol 38:771-777, Olanow,C.W.,et al, 1995

Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's Disease
Arch Neurol 52:1183-1190, Antonini,A.,et al, 1995

MRI In Patients with Suspected Vascular Parkinsonism
Neurol 45:2183-2188, Jijlmans,J.C.M.,et al, 1995

Early Differential Diagnosis of Parkinson's Disease with F-flurodeoxyglucose and Positron Emission Tomography
Neurol 45:1995-2004, Eidelberg,D.,et al, 1995

Effect of GPi Pallidotomy on Motor Function in Parkinson's Disease
Lancet 346:1383-1387, Lozano,A.M.,et al, 1995

Clinical and[18F]dopa PET Findings in Early Parkinson's Disease
JNNP 59:597-600, Morrish,P.K.,et al, 1995

Campylobacter Jejuni Infection and Guillain-Barre Syndrome
NEJM 333:1374-1379, 14151995., Rees,J.H.,et al, 1995

Parkinsonism-Recognition and Differential Diagnosis
BMJ 310:447-452, Quinn,N., 1995

Increased Incidence of Levodopa Therapy Following Metoclopramide Use
JAMA 274:1780-1782, Avorn,J.,et al, 1995

Dopa-Responsive parkinsonism Phenotype of Machado-Jospeh Disease:Confirmation of 14q CAG Expansion
Ann Neurol 48:684-687, Tuite,P.J.,et al, 1995

Image Analysis of B-Amyloid Load in Alzheimer's Disease and Relation to Dementia Severity
Lancet 346:1524-1528, Cummings,B.J.&Cotman,C.W., 1995

Multiple System Atrophy presenting as Parkinsonism:Clinical Features and Diagnostic Criteria
JNNP 59:144-151, Albanese,A.,et al, 1995

Occurrence of Different Cancers in Patients with Parkinson's Disease
BMJ 310:1500-1501, Moller,H.,et al, 1995

Neuropath Evid of Graft Survival & Striatal Reinnerva after Transpl of Fetal Mesencephalic Tissue in Parkinson's Dis
NEJM 332:1118-1124, 11631995., Kordower,J.H.,et al, 1995

Bilateral Fetal Nigral Transplantation Into the Postcommissural Putamen in Parkinson's Disease
Ann Neurol 38:379-388, Freemen,T.B.,et al, 1995

Stereotactic Ventral Pallidotomy for Parkinson's Disease
Neurol 45:753-761, Dogali,M.,et al, 1995

Electroconvulsive Therapy for the Physical Signs of Parkinson's Disease Without Depressive Disorder
JNNP 58:641-642, Pridmore,S.,et al, 1995

Psychosis in Advanced Parkinson's Disease:Treatment with Ondansetron, a 5-HT3 Receptor Antagonist
Neurol 45:1305-1308, Zoldan,J.,et al, 1995

Parkinsonism Unmasked by Lovastatin
Ann Neurol 37:685-686, Muller,T.,et al, 1995

Psychogenic Parkinsonism
Arch Neurol 52:802-810, Lang,A.E.,et al, 1995

Risk Factors for Lacunar Infarction Syndromes
Neurol 45:1483-1487, You,R.,et al, 1995

Hemiballismus:CT and MR Findings
J Comput Assist Tomogr 19:537-540, Provenzale,J.M.&Glass,J.P., 1995

Vasospasm and Thrombus Formation as Possible Mechanisms of Stroke Related to Alkaloidal Cocaine
Stroke 26:1114-1118, Konzen,J.P.,et al, 1995

Neuroleptic Drug Exposure and Treatment of Parkinsonism in the Elderly:A Case-Control Study
Am J Med 99:48-54, Avorn,J.,et al, 1995

Apolipoprotein E Genotype in Diverse Neurodegenerative Disorders
Ann Neurol 38:131-135, Schneider,J.A.,et al, 1995

Exacerbation of Idiopathic Parkinson's Disease by Naproxen
BMJ 311:422, Shaunak,S.,et al, 1995

Encephalopathy with Parkinsonian Features in Children Following Bone Marrow Transplantations and High-Dose Amphotericin B
Ann Neurol 37:810-814, Mott,S.H.,et al, 1995

Dementia Associated with the Acquired Immunodeficiency Syndrome
NEJM 332:934-940, Lipton,S.A.&Gendelman,H.E., 1995

The Use of Sumatriptan in Patients with Monoamine Oxidase Inhibitors
Neurol 45:1039-1040, Diamond,S., 1995

Comparative Study of Selegiline Plus L-Dopa-Carbidopa VS L-Dopa-Carbidopa Alone in Trtm of Parkinson's Disease
Ann Neurol 37:95-98, Brannan,T.&Yahr,M.D., 1995

Clinicopathological Study of 35 Cases of Multiple System Atrophy
JNNP 58:160-166, Wenning,G.K.,et al, 1995



Showing articles 900 to 950 of 1815 << Previous Next >>